Olaparib in ovarian cancer with BRCA mutation

被引：5

作者：

Pujade-Lauraine, Eric ^{[1
]}

Combe, Pierre ^{[2
]}

机构：

[1] GH Paris Ctr, Ctr Canc Femme & Rech Clin, F-75181 Paris 04, France

[2] Hop Europeen Georges Pompidou, Serv Oncol Med, F-75015 Paris, France

来源：

BULLETIN DU CANCER | 2015年 / 102卷 / 06期

关键词：

BRCA; Ovarian cancer; Olaparib; PARP;

D O I：

10.1016/S0007-4551(15)31221-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

With 4500 new cases and 3200 death each year, ovarian cancer is the first cause of mortality for gynecological cancer in France. Without any efficient screening, it is usually diagnosed around the age of 60 years at an advanced stage. The emergence of olaparib, a new targeted therapy, represents a major opportunity.

引用

页码：S82 / S84

页数：3

共 50 条

[41] BRCA germline mutation test for all woman with ovarian cancer?
Paradiso, A. V.
Digennaro, M.
Patruno, M.
De Summa, S.
Tommasi, S.
Berindan-Neagoe, I.
BMC CANCER, 2019, 19 (1)
[42] Risk management guidelines for ovarian cancer in BRCA mutation carriers
Lichert, Frank
GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (02)
[43] New treatment strategy for ovarian cancer with a BRCA gene mutation
Shoji, Tadahiro
Kikuchi, Kotoka
Kogita, Hayato
Jonai, Nanako
Tomabechi, Hidetoshi
Kudoh, Akiko
Takatori, Eriko
Nagasawa, Takayuki
Kagabu, Masahiro
Baba, Tsukasa
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (01) : 1 - 9
[44] Value of Prophylactic Mastectomy in BRCA Mutation Carriers with Ovarian Cancer
Gamble, C. R.
Havrilesky, L.
Hollenbeck, S.
Myers, E.
Greenup, R.
ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S61 - S61
[45] CURRENT GUIDANCE FOR BRCA MUTATION TESTING IN OVARIAN CANCER PATIENTS
Ehlken, B.
Driedger, J.
Hofmann-Xu, L.
Paulus, G.
Berger, K.
de Moor, C.
Schroeder, C.
Clune, J.
Tyczynski, J.
VALUE IN HEALTH, 2014, 17 (07) : A663 - A663
[46] Breast and ovarian cancer risk varies by BRCA mutation type
Nature Reviews Clinical Oncology, 2015, 12 (7) : 374 - 374
[47] OVARIAN CANCER ONSET ACROSS DIFFERENT BRCA MUTATION TYPE
Marchetti, C.
D'indinosante, M.
Minucci, A.
Giaco, L.
Cassani, C.
La Cava, G.
Ergasti, R.
Scambia, G.
Fagotti, A.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A269 - A269
[48] BRCA germline mutation test for all woman with ovarian cancer?
A. V. Paradiso
M. Digennaro
M. Patruno
S. De Summa
S. Tommasi
I. Berindan-Neagoe
BMC Cancer, 19
[49] Adjuvant olaparib - High risk early breast cancer with BRCA1 or BRCA2 germline mutation
Bonneau, Maeva
Bellesoeur, Audrey
BULLETIN DU CANCER, 2023, 110 (11) : 1092 - 1093
[50] BRCA mutation in ovarian cancer: testing, implications and treatment considerations
Neff, Robert T.
Senter, Leigha
Salani, Ritu
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2017, 9 (08) : 519 - 531

← 1 2 3 4 5 →